Picture of DURECT logo

DRRX DURECT Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for DURECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.582-36.3-35.3-27.6-8.32
Depreciation
Non-Cash Items-10.43.032.88-8.16-8.92
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-28-4.366.061.34-1.92
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-38.7-37.3-26.3-34.4-19.1
Capital Expenditures-0.208-0.194-0.111-0.0520
Purchase of Fixed Assets
Other Investing Cash Flow Items9.6415.519.9-1.1118
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities9.4315.319.8-1.1718
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities15.750.50.08320.5-16.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-13.628.5-6.36-15.1-17.4